SEC Form 4 · accession 0001193125-26-266155
Rapport Therapeutics, Inc. · RAPP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Maraganore
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 10, 2026 · 5:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002012593
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $35.21 | Jun 10, 2026 | A | 15,200 | A | — | Jun 10, 2036 | Common Stock | 15,200 | 15,200 | D |
Explanation of responses
- F1The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.